IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.062
EU - Europa 11.256
AS - Asia 6.023
SA - Sud America 2.087
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
AN - Antartide 1
Totale 37.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.905
RU - Federazione Russa 5.380
SG - Singapore 2.363
BR - Brasile 1.834
CN - Cina 1.613
IE - Irlanda 1.461
SE - Svezia 1.244
VN - Vietnam 902
UA - Ucraina 728
IT - Italia 634
DE - Germania 597
HK - Hong Kong 542
FR - Francia 328
FI - Finlandia 303
GB - Regno Unito 266
IN - India 145
AR - Argentina 81
CA - Canada 72
TR - Turchia 69
BD - Bangladesh 67
AT - Austria 51
IQ - Iraq 48
ZA - Sudafrica 47
MX - Messico 45
CZ - Repubblica Ceca 42
EC - Ecuador 42
MA - Marocco 41
BE - Belgio 40
NL - Olanda 40
UZ - Uzbekistan 38
CO - Colombia 34
PL - Polonia 32
VE - Venezuela 30
PK - Pakistan 29
ID - Indonesia 25
IR - Iran 25
ES - Italia 23
CL - Cile 19
JP - Giappone 19
TN - Tunisia 19
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
PE - Perù 16
CI - Costa d'Avorio 15
DZ - Algeria 15
PY - Paraguay 15
JM - Giamaica 12
NP - Nepal 12
RO - Romania 12
UY - Uruguay 12
LV - Lettonia 11
CH - Svizzera 10
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
EG - Egitto 9
GE - Georgia 9
EU - Europa 8
MY - Malesia 8
SN - Senegal 8
AU - Australia 7
KG - Kirghizistan 7
LT - Lituania 7
BY - Bielorussia 6
JO - Giordania 6
KZ - Kazakistan 6
PA - Panama 6
AL - Albania 5
AM - Armenia 5
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KR - Corea 5
TT - Trinidad e Tobago 5
AO - Angola 4
ET - Etiopia 4
KW - Kuwait 4
LB - Libano 4
PH - Filippine 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
LU - Lussemburgo 3
OM - Oman 3
RS - Serbia 3
BG - Bulgaria 2
GA - Gabon 2
HU - Ungheria 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
Totale 37.609
Salva come PNG Salva come JPEG
Città #
Dallas 9.888
Moscow 1.695
Dublin 1.459
Jacksonville 1.382
Singapore 1.229
Chandler 949
Ashburn 890
Nyköping 812
Dong Ket 629
Beijing 545
Hong Kong 539
San Jose 309
Princeton 265
The Dalles 256
Cambridge 254
Medford 232
Lauterbourg 219
Dearborn 216
Los Angeles 195
Des Moines 189
Boardman 152
Ann Arbor 143
Messina 140
São Paulo 121
Buffalo 113
Ho Chi Minh City 98
Milan 98
Tianjin 95
Munich 89
New York 78
San Mateo 75
Lancaster 69
Jinan 68
Hanoi 61
Guangzhou 60
Wilmington 58
Redondo Beach 57
Council Bluffs 56
Rio de Janeiro 55
Woodbridge 54
Belo Horizonte 50
Vienna 48
Shenyang 45
Houston 37
Brooklyn 36
Brussels 36
Nanjing 36
Orem 36
Tashkent 36
Brno 35
Porto Alegre 34
Frankfurt am Main 32
Shenzhen 32
Augusta 30
Santa Clara 30
Amsterdam 28
Warsaw 28
Haikou 27
Johannesburg 27
Chicago 26
Hyderabad 26
Pune 26
Zhengzhou 26
Helsinki 24
Montreal 24
Stockholm 24
Brasília 23
Campinas 23
Seattle 23
Chennai 22
Curitiba 21
Fuzhou 21
Taizhou 21
Turku 21
Hebei 19
London 19
Mumbai 19
Ningbo 19
Salvador 19
Shanghai 19
St Petersburg 19
Ardabil 18
Baghdad 18
Changsha 17
Denver 17
Rome 17
Tokyo 17
Boston 16
Istanbul 16
Quito 16
Abidjan 15
Da Nang 15
Nanchang 15
Norwalk 15
Nuremberg 15
Atlanta 14
Dhaka 14
Guarulhos 14
Haiphong 14
Manaus 14
Totale 25.336
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.729
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.709
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 298
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 291
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 278
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 270
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 260
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 254
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 251
1-Adamantanamine derivatives as potential anti-HIV agents 250
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 240
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 199
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 198
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 192
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 192
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 190
Cap. 21 - Antitrombotici 189
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 187
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 187
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 185
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 179
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 177
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 172
2,3-Benzodiazepines as potential AMPA receptors antagonists 170
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 168
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 168
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 168
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 164
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 163
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 160
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 160
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 159
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 158
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 158
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 157
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 157
Derivati adamantanici a potenziale attività antivirale. 156
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 155
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 151
Annelated 1,5-benzothiazepines 151
Development of novel amides as non covalent inhibitors of immunoproteasome 150
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 149
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 147
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 147
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 147
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 147
Evaluation of curcumin irreversibility 146
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 145
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 144
Falcipain-2 inhibitors 144
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 144
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 144
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 143
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 143
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 142
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 140
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 139
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 136
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 135
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 135
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 135
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 133
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 131
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 130
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 130
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 130
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 129
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 126
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 126
Vincamina: sintesi e caratteristiche spettroscopiche 125
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 123
Development of peptidomimetic boronates as proteasome inhibitors 123
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 123
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 122
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 122
Glutamate Binding-Site Ligands of NMDA Receptors 121
Development of peptidomimetic boronates as proteasome inhibitors 121
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 121
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 121
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 119
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 119
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 117
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 117
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 117
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 116
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 115
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 114
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 114
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 114
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 113
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 113
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 113
Composti a presumibile attività antitumorale. IV - Sintesi ed attività antileucemica di N,N'-di-[2-(1,3,4-tiadiazolil)]metilendiamine 1-sostituite 112
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 112
Sintesi ed attività di nuovi agenti antiipertensivi. 112
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 112
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 112
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 111
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 110
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 110
Totale 24.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021684 0 0 0 0 0 0 0 0 0 0 0 684
2021/20221.643 10 350 30 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202620.763 419 3.321 7.312 1.057 853 2.994 1.443 1.414 1.310 367 177 96
Totale 37.988